THE INTEGRATED ABC/FMR/VED-ANALYSIS OF DRUG CONSUMPTION AMONG HOSPICE PATIENTS
AbstractOne of the problematic aspects of palliative-hospice care is pharmaceutical providing of the patients at specialized institutions, hospices. The relevance of the work is due to the lack of research about the medicineconsumption by patients at the hospice in Ukraine. Therefore the aim of the research was to study the range, cost, prescription frequency and the cost of patient pharmacotherapy at the hospice.The methods of content and frequency analysis and also,the integrated ABC/FMR/VED-analysis were used for the study.At the first research stagewere analyzed the clinical and basic statistical characteristics of hospice patients. At the second stage, the integrated ABC/FMR/VED analysis of prescribed drugs has been conducted. Then the definition of frequently prescribed medications and main therapeutic groups, using frequency analysis,hasbeen performed. The final step is the calculation of patients pharmacotherapy cost and the individual therapeutic medicationgroups.The analysis of clinical and statistical characteristics of hospice patients has showed that 75.6% of patients at the hospice were women and 48.9% of all diseases present were cardiovascular diseases. 139 medicinal products have beenprescribedto patients. It has been discovered that 20 (14.4%) drugs makean AFV group – the most frequentlyprescribed medications with the largest cost of consumed dose units on the base of the integrated ABC/FMR/VED-analysis. The cost of patient pharmacotherapy has been calculated and there has been found the moderate direct correlation with the time spent atthe hospice.
Article Information
12
104-109
590KB
1522
English
IJPSR
Sofiya Prokip* and Bohdan Hromovyk
Department of Organization and Economics of Pharmacy, Faculty of Pharmacy, Danylo Halytskyi Lviv National Medical University 1, 75 Pekarska str., Lviv, 79010, Ukraine
sofiyaprokip@gmail.com
29 August, 2013
15 October, 2013
26 December, 2013
http://dx.doi.org/10.13040/IJPSR.0975-8232.5(1).104-09
01 January, 2014